Offer - Urjas Oil for just ₹ 1 X
Ambrolite D Plus is a commercial drug that is prescribed in the form of Syrup. It is primarily used for the treatment of Cough, Common Cold. Other than this, Ambrolite D Plus has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Ambrolite D Plus is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Ambrolite D Plus as well, which are listed below. Usually, these side effects of Ambrolite D Plus go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Ambrolite D Plus has a Moderate effect for pregnant women and Moderate effect on lactating mothers. In addition, Ambrolite D Plus's effects on the liver, heart and kidney are discussed below in the Ambrolite D Plus related warnings section.
Ambrolite D Plus is not recommended if you suffer from certain medical conditions as it can have adverse effects. Heart Disease are examples of such conditions. The section on Ambrolite D Plus contraindications lists all such conditions.
Drug interactions for Ambrolite D Plus have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Ambrolite D Plus, it is important to know that it is not safe while driving, and is not habit-forming.
Ambrolite D Plus is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Ambrolite D Plus safe for pregnant women?
Ambrolite D Plus may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Ambrolite D Plus again without your doctor's advice.
Is the use of Ambrolite D Plus safe during breastfeeding?
Breastfeeding women can take Ambrolite D Plus as it bears very minor side effects for them.
What is the effect of Ambrolite D Plus on the Kidneys?
Ambrolite D Plus has very mild side effects on the kidneys.
What is the effect of Ambrolite D Plus on the Liver?
Side effects of Ambrolite D Plus rarely affect the liver.
What is the effect of Ambrolite D Plus on the Heart?
Side effects of Ambrolite D Plus rarely affect the heart.
Ambrolite D Plus should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Ambrolite D Plus unless your doctor advises you to do so -
Is this Ambrolite D Plus habit forming or addictive?
No, you will not get addicted to Ambrolite D Plus.
Interaction between Food and Ambrolite D Plus
Taking Ambrolite D Plus with food is safe.
Interaction between Alcohol and Ambrolite D Plus
No research has been done on this till date. Therefore, it is not known what the effect of taking Ambrolite D Plus with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,165
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 422-423
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 220
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vazculep (phenylephrine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 135-136
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1020-1022